北京商报讯（记者 马换换 李佳雪）2月5日晚间，天汽模（002510）披露公告称，公司正在筹划通过发 行股份及支付现金的方式购买东实汽车科技集团股份有限公司（以下简称"东实股份"）股权并募集配套 资金。公司股票自2月6日起开始停牌。 值得一提的是，东实股份曾有过一段冲击IPO未果的经历。深交所官网显示，公司主板IPO于2023年5月 25日获得受理，并于当年6月25日进入问询阶段，不过，公司IPO于2024年5月17日撤单，冲A折戟。 公告显示，本次交易预计构成重大资产重组，构成关联交易，不构成重组上市。公司预计在不超过10个 交易日内披露本次交易方案，即在3月2日前按照要求披露相关信息，并申请复牌。 据悉，东实股份是一家从事汽车零部件研发、制造与销售的大型集团公司。 ...

Group 1 - Zhenghe Ecology signed a strategic cooperation agreement with the government of Miyun District, Beijing, to provide comprehensive services in water safety, resources, ecology, and technology [2] - GCL-Poly Energy announced that it has not yet received any orders in the "space photovoltaic" sector, which remains in the technical exploration stage with uncertain commercial prospects [3] - Changxin Bochuang's shareholder Zhu Wei terminated the transfer of 5.04% of the company's shares, retaining a total of 7.16% of the company's shares [4] - Tianqimo is planning to acquire equity in Dongshi Automotive Technology Group through a combination of share issuance and cash payment, leading to a suspension of trading [5] Group 2 - Hengwei Technology reported a net profit of 34.938 million yuan for 2025, a year-on-year increase of 30.13%, despite a revenue decline of 6.31% to 1.047 billion yuan [7] - Xianheng International's controlling shareholder and associated parties plan to reduce their holdings by up to 3% of the company's shares [9] - Kangpeng Technology's shareholder Wuxi Yunhui intends to reduce its stake by up to 2.94%, while two other shareholders plan to collectively reduce their holdings by up to 2.28% [10] Group 3 - Southeast Network Framework won a bid for an EPC project worth 994 million yuan [12] - Rongfa Nuclear Power's wholly-owned subsidiary won a project from China General Nuclear Power Corporation valued at 101 million yuan [13] - Taiji Industry's subsidiary is expected to win a bid for the Huahong FAB9B project with a bid amount of 3.778 billion yuan [14]

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

格隆汇2月5日丨天汽模(002510.SZ)公布，公司正在筹划通过发行股份及支付现金的方式购买东实汽车 科技集团股份有限公司（简称"标的公司"、"东实股份"）股权并募集配套资金。根据《上市公司重大资 产重组管理办法》等相关法律法规规定，本次交易预计构成重大资产重组，构成关联交易，不构成重组 上市。因有关事项尚存在不确定性，为了维护投资者利益，避免对公司证券交易造成重大影响，根据深 圳证券交易所的相关规定，经公司申请，公司证券自2026年2月6日（星期五）开市起开始停牌。 ...

（记者 王晓波） 每经头条（nbdtoutiao）——仅老年独居者就数千万，谁能帮他们从容老去？意定监护在国内诞生已14 年，距全面落地还差"最后一公里" 每经AI快讯，天汽模2月5日晚间发布公告称，天津汽车模具股份有限公司正在筹划通过发行股份及支 付现金的方式购买东实汽车科技集团股份有限公司股权并募集配套资金。本次交易预计构成重大资产重 组，构成关联交易，不构成重组上市。因有关事项尚存在不确定性，为了维护投资者利益，避免对公司 证券交易造成重大影响，经公司申请，公司证券自2026年2月6日（星期五）开市起开始停牌。 ...

本次交易事项尚处于筹划阶段，公司目前初步确定的交易对方为德盛拾陆号企业管理(天津)合伙企业(有 限合伙)(简称"德盛16号")。 天汽模（002510）(002510.SZ)公告，公司正在筹划通过发行股份及支付现金的方式购买东实汽车科技 集团股份有限公司("东实股份")股权并募集配套资金。公司股票自2026年2月6日(星期五)开市起开始停 牌。 ...

智通财经APP讯，天汽模(002510.SZ)公告，公司正在筹划通过发行股份及支付现金的方式购买东实汽车 科技集团股份有限公司("东实股份")股权并募集配套资金。公司股票自2026年2月6日(星期五)开市起开 始停牌。 本次交易事项尚处于筹划阶段，公司目前初步确定的交易对方为德盛拾陆号企业管理(天津)合伙企业(有 限合伙)(简称"德盛16号")。 ...

股票代码:002510 公司简称：天汽模 公告编号 2026-005 天津汽车模具股份有限公司 关于筹划重大资产重组事项的停牌公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没 有虚假记载、误导性陈述或重大遗漏。 一、停牌事由和工作安排 天津汽车模具股份有限公司（以下简称"公司"）正在筹划通过发行股份及 支付现金的方式购买东实汽车科技集团股份有限公司（以下简称"标的公司"、 "东实股份"）股权并募集配套资金（以下简称"本次交易"或"本次重组"）。 根据《上市公司重大资产重组管理办法》等相关法律法规规定，本次交易预计构 成重大资产重组，构成关联交易，不构成重组上市。 公司预计在不超过 10 个交易日内披露本次交易方案，即在 2026 年 3 月 2 日（星期一）前按照《公开发行证券的公司信息披露内容与格式准则第 26 号—— 上市公司重大资产重组》的要求披露相关信息，并申请复牌。 若公司未能在上述期限内召开董事会审议并披露交易方案，公司证券最晚将 于 2026 年 3 月 2 日（星期一）开市起复牌并终止筹划相关事项，同时披露停牌 期间筹划事项的主要工作、事项进展、对公司的影响以及后续安排等事项，充 ...

股票代码：002510 公司简称：天汽模 公告编号 2026-004 天津汽车模具股份有限公司 关于高级管理人员股份减持计划时间届满 未实施减持的公告 一、股份减持计划实施进展情况 根据《上市公司股东减持股份管理暂行办法》《深圳证券交易所上市公司自 律监管指引第 18 号——股东及董事、高级管理人员减持股份》等有关规定，现 将本次股份减持计划实施情况公告如下： 邓应华先生计划以集中竞价方式减持本公司股份不超过 14,139 股。截至本 公告披露日，本次减持计划时间届满，减持计划尚未实施。邓应华先生仍持有本 公司股份 56,557 股，占本公司总股本比例为 0.0056%。 二、相关风险提示 1、本次减持计划的实施符合《中华人民共和国证券法》《上市公司收购管 理办法》《上市公司股东减持股份管理暂行办法》《深圳证券交易所上市公司自 律监管指引第 18 号——股东及董事、高级管理人员减持股份》等法律法规及公 司规章制度。 2、截至本公告披露日，本次减持计划期限已届满。本次减持股份事项已按 照相关规定进行了预披露，邓应华先生在本次减持计划期间内未减持其所持有的 公司股份，不存在违反减持计划和相关承诺的情况。 3、公司 ...

声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 国家知识产权局信息显示，天津汽车模具股份有限公司取得一项名为"一种汽车零件生产用冲孔模具"的 专利，授权公告号CN223847889U，申请日期为2025年3月。 专利摘要显示，本实用新型公开了一种汽车零件生产用冲孔模具，涉及汽车零件生产设备技术领域，包 括底座、第一支撑架和第二支撑架，所述底座顶部的边缘设置有第一支撑架，所述第一支撑架的一侧设 置有第二支撑架，且第二支撑架的另一端设置于底座顶部的边缘，本实用新型通过底座的凹槽、安装 槽、滚珠与转动盘外壁的活动连接，以及齿轮盘在环形槽内的活动设置，有利于提高转动盘旋转的顺畅 性，底座外壁设置的驱动组件能有效驱动转动盘和齿轮盘转动，提高操作效率，此外，转动盘顶部的移 动槽内设置的一组夹持块，通过调节组件确保了对不同尺寸汽车零件的精准夹持，进而有利于提高冲孔 模具结构紧凑和操作便捷，能够显著提高对汽车零件的生产效率和加工精度。 天眼查资料显示，天津汽车模具股份有限公司，成立于1996年，位于天津市，是一家以从事汽车制造业 为主的企业。企业注册资本101513.8708万人民 ...